Lambumiz's RAS net profit for 9 months of 2024 amounted to ₽217.97 million, up 43.5% from ₽151.87 million in the previous year. Revenue rose 10.6% to ₽2.09 billion against ₽1.89 billion a year earlier.

Lambumiz IPO amounted to ₽802 million. Raised funds will be used by the company to implement its growth strategy - construction of an additional production complex with an area of over 14 thousand square meters on the basis of the existing territory to accommodate new aseptic packaging production and expansion of the company's capacity within the current ran...

Lambumiz's board of directors has set the IPO offering price at ₽425 per share, which corresponds to the lower end of the pre-money valuation price range of ₽8 billion. Raised funds are to be used by the company to build an aseptic packaging plant. Trading in the shares will begin on October 30 under the ticker LMBZ.

Lambumiz has set the IPO price range at ₽425-460 per share, corresponding to a pre-money valuation of ₽8.018-8.678 billion. Planned offering size will be ₽0.8-1 billion. Post-IPO free-float could be around 10-12%. Collection of applications begins today and will last until October 29. Trading in the shares will begin on October 30 under the ticker LMBZ.